دورية أكاديمية
Trends in International Cancer Research Investment 2006-2018.
| العنوان: | Trends in International Cancer Research Investment 2006-2018. |
|---|---|
| المؤلفون: | Abudu R; London School of Hygiene and Tropical Medicine, London, United Kingdom., Bouche G; Anticancer Fund, Brabant, Belgium., Bourougaa K; Institut National du Cancer, Boulogne-Billancourt, France., Davies L; International Cancer Research Partnership, Cardiff, United Kingdom., Duncan K; US National Cancer Institute, Bethesda, MD., Estaquio C; Institut National du Cancer, Boulogne-Billancourt, France., Font AD; World Cancer Research Fund International, London, United Kingdom., Hurlbert MS; Melanoma Research Alliance, Washington, DC., Jackson P; Cancer Australia, Surry Hills, NSW, Australia., Kroeskop-Bossenbroek L; Dutch Cancer Society, Amsterdam, the Netherlands., Lewis I; National Cancer Research Institute, London, United Kingdom., Mitrou G; World Cancer Research Fund International, London, United Kingdom., Mutabbir A; National Cancer Research Institute, London, United Kingdom., Pettigrew CA; National Breast Cancer Foundation, Sydney, NSW, Australia., Turner L; Worldwide Cancer Research HQ, Edinburgh, United Kingdom., Weerman A; Dutch Cancer Society, Amsterdam, the Netherlands., Wojtanik K; Susan G. Komen, Dallas, TX. |
| المصدر: | JCO global oncology [JCO Glob Oncol] 2021 Apr; Vol. 7, pp. 602-610. |
| نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101760170 Publication Model: Print Cited Medium: Internet ISSN: 2687-8941 (Electronic) Linking ISSN: 26878941 NLM ISO Abbreviation: JCO Glob Oncol Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Alexandria, VA : American Society of Clinical Oncology, [2020]- |
| مواضيع طبية MeSH: | Biomedical Research* , Pancreatic Neoplasms*, Databases, Factual ; Humans ; Investments |
| مستخلص: | The International Cancer Research Partnership (ICRP) is an active network of cancer research funding organizations, sharing information about funded research projects in a common database. Data are publicly available to enable the cancer research community to find potential collaborators and avoid duplication. This study presents an aggregated analysis of projects funded by 120 partner organizations and institutes in 2006-2018, to highlight trends in cancer research funding. Overall, the partners' funding for cancer research increased from $5.562 billion (bn) US dollars (USD) in 2006 to $8.511bn USD in 2018, an above-inflation increase in funding. Analysis by the main research focus of projects using Common Scientific Outline categories showed that Treatment was the largest investment category in 2018, followed by Early Detection, Diagnosis, and Prognosis; Cancer Biology; Etiology; Control, Survivorship, and Outcomes; and Prevention. Over the 13 years covered by this analysis, research funding into Treatment and Early Detection, Diagnosis, and Prognosis had increased in terms of absolute investment and as a proportion of the portfolio. Research funding in Cancer Biology and Etiology declined as a percentage of the portfolio, and funding for Prevention and Control, Survivorship and Outcomes remained static. In terms of cancer site-specific research, funding for breast cancer and colorectal cancer had increased in absolute terms but declined as a percentage of the portfolio. By contrast, investment for brain cancer, lung cancer, leukemia, melanoma, and pancreatic cancer increased both in absolute terms and as a percentage of the portfolio. Competing Interests: Lynne DaviesConsulting or Advisory Role: Innovate UK grant to Proximie Ltd/Cardiff & Vale University Health Board Paul JacksonStock and Other Ownership Interests: CSL Limited Marc S. HurlbertUncompensated Relationships: PfizerNo other potential conflicts of interest were reported. |
| References: | Gastroenterology. 2017 Apr;152(5):918-921.e2. (PMID: 28259790) Lancet Oncol. 2019 Dec;20(12):e672-e684. (PMID: 31797794) JNCI Cancer Spectr. 2019 Oct 07;3(4):pkz069. (PMID: 32337488) Reprod Toxicol. 2015 Jul;54:11-8. (PMID: 25277312) Biometrics. 1977 Mar;33(1):159-74. (PMID: 843571) Psychol Bull. 1968 Oct;70(4):213-20. (PMID: 19673146) CA Cancer J Clin. 2018 Nov;68(6):394-424. (PMID: 30207593) |
| تواريخ الأحداث: | Date Created: 20210428 Date Completed: 20210805 Latest Revision: 20210805 |
| رمز التحديث: | 20240628 |
| مُعرف محوري في PubMed: | PMC8162963 |
| DOI: | 10.1200/GO.20.00591 |
| PMID: | 33909474 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2687-8941 |
|---|---|
| DOI: | 10.1200/GO.20.00591 |